• 李军锋:按照一个“π”提出“314” 落实全国高校思政工作会议精神 2019-07-16
  • 今年全军院校将招生三万余名 2019-07-16
  • 不爱做这7件事的人,对不起!你的听力可能早就损伤了 2019-06-10
  • 1230余万元省级福彩公益金助力宿迁24个公益项目 2019-06-09
  • 特斯拉亏损扩大 未来利润或受美关税影响 2019-06-08
  • 农工党黑龙江省委开展“美丽中国,我是行动者”活动 2019-06-08
  • 中国双阳梅花鹿产业技术创新战略联盟成立大会召开 2019-06-07
  • 安徽砀山:微型消防站培训“四步走” 队员齐学“真本领” 2019-06-06
  • 天上不会掉馅饼,想要富起来,就要把别人的据为己有,能把别人的据为己有的问世间能有谁,能有几人,所谓的专家明白了吗。 2019-06-06
  • 镇江市人大常委会召开会议 表决通过人事任免 2019-06-05
  • 目前的缓和,是美国中期选举特郎普需要外交得分。 2019-06-04
  • 徐海东在周家岗设伏歼敌 2019-06-03
  • 个税法修正案草案增反避税条款堵税收漏洞 2019-06-03
  • 甘坐冷板凳 勇做栽树人(科技创新系列谈②) 2019-06-02
  • 反思“天价账单”要看共性问题 2019-06-01
  • 贵阳雀友麻将机维修
    CHINESE|贵阳雀友麻将机维修
    Location:贵阳雀友麻将机维修 > Company News > Business Events

    麻将摆出的形状:Dr. Gilbert Wen Invited to be Host and Keynote Speaker for Biomedical Innovation and Entrepreneurshi

    Time:2017-06-10 17:15:44  Form:  Writer:

    贵阳雀友麻将机维修 www.bcmfs.tw  

    On June 9, 2017, the second annual conference of the Biomedical Innovation and Entrepreneurship Summit was successfully held in China Medical City, Taizhou, Jiangsu Province. Dr. Gilbert (Xiaoguang) Wen, founder and CEO of Overseas Pharmaceutical, Ltd. (OPL) was invited to host the opening ceremony of the conference. Later, in the forum section, Dr. Wen was invited to give a keynote speech titled: "Using the Development of Controlled-Released Products as an Example to Discuss New Strategies for Novel Drug Development Through FDA 505(b)(2) Regulatory Pathway and CFDA Second Category Drugs.” In the lecture, Dr. Wen presented what and how to fulfill the US FDA 505(b)(2) regulatory pathway and made a comparison between FDA and CFDA polices regarding the regulatory affairs, describing these two classes of innovative medicines waiting to be excavated as a piece of undervalued gold. Dr. Wen demonstrated that over the past ten years, oral controlled-release drugs made up around half of the total new drug approvals (NDA); compared the FDA 505(b)(2) and 505(b) return paths (1) and 505 (J); and finally, Wen also shared with the audience the development process for Lamictal XR, Requip XR and other sustained-release tablets as examples to explain the importance of the development of platform technologies and taking these advanced proprietary technologies for oral controlled-release drugs.

            23-cover-20170612230692.jpg

    During the evening roadshow section, Dr. Wen showed our project "Controlled-Release Drug Development Platform Technology Application Innovation (NDA/modified drugs),” with a focus on our proprietary platform technologies and the current progress of our product development based on the NDA and ANDA pipelines. We displayed clinical data of new pain-relief product OPL-004, which attracted many investors and pharmaceutical enterprises interested in investment for the new drug development. Afterwards, they approached Dr. Wen and exchanged ideas and engaged in more in-depth discussions. Our company is looking forward to cooperation with these parties in the future.

    In the morning, before the opening ceremony, invited guests and experts visited the Overseas Pharmaceutical company headquarters. Dr. Fred (Fengde) Xi, Chief Scientific Officer (CSO) and senior VP, led the tour, introduced the details of the company, and visited the company's R&D laboratory, as well as equipment and facilities.

  • 李军锋:按照一个“π”提出“314” 落实全国高校思政工作会议精神 2019-07-16
  • 今年全军院校将招生三万余名 2019-07-16
  • 不爱做这7件事的人,对不起!你的听力可能早就损伤了 2019-06-10
  • 1230余万元省级福彩公益金助力宿迁24个公益项目 2019-06-09
  • 特斯拉亏损扩大 未来利润或受美关税影响 2019-06-08
  • 农工党黑龙江省委开展“美丽中国,我是行动者”活动 2019-06-08
  • 中国双阳梅花鹿产业技术创新战略联盟成立大会召开 2019-06-07
  • 安徽砀山:微型消防站培训“四步走” 队员齐学“真本领” 2019-06-06
  • 天上不会掉馅饼,想要富起来,就要把别人的据为己有,能把别人的据为己有的问世间能有谁,能有几人,所谓的专家明白了吗。 2019-06-06
  • 镇江市人大常委会召开会议 表决通过人事任免 2019-06-05
  • 目前的缓和,是美国中期选举特郎普需要外交得分。 2019-06-04
  • 徐海东在周家岗设伏歼敌 2019-06-03
  • 个税法修正案草案增反避税条款堵税收漏洞 2019-06-03
  • 甘坐冷板凳 勇做栽树人(科技创新系列谈②) 2019-06-02
  • 反思“天价账单”要看共性问题 2019-06-01
  • 平特复式连怎么赔 天津十一选五开奖结果查询 福彩3d开奖 斯图加特地图 魔兽世界配置 富裕人生走势图 极速赛车游戏 伯恩茅斯vs斯旺西 富勒姆vs纽卡斯尔 海底世界APP